Education
About Us
Working with TipRanks
Follow Us
GSEU - AI Analysis
Top Page
Goldman Sachs ActiveBeta Europe Equity ETF (GSEU)
Rating:63Neutral
Price Target:
$47.00
Positive Factors
Strong Top Holdings
Several key holdings, such as ASML Holding NV and Nestlé SA, have shown strong year-to-date performance, supporting the ETF's overall returns.
Low Expense Ratio
The ETF has a competitive expense ratio of 0.25%, making it cost-effective compared to many actively managed funds.
Broad Geographic Exposure
The fund invests across multiple European countries, reducing reliance on any single economy.
Negative Factors
Underperforming Holdings
Some top holdings, such as SAP SE, have lagged in performance, which could weigh on future returns.
Sector Concentration in Financials
With over 22% of the portfolio in the financial sector, the ETF is heavily exposed to sector-specific risks.
Limited U.S. Exposure
The ETF has minimal exposure to U.S. companies, which could limit diversification in a global context.
GSEU vs. SPDR S&P 500 ETF (SPY)
AUM113.27M
RegionEurope
Expense Ratio0.25%
Beta0.66
IssuerGoldman Sachs
Inception DateMar 02, 2016
Dividend Yield2.02%
Asset ClassEquity
Index TrackedGoldman Sachs ActiveBeta Europe Equity
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume7,970
30 Day Avg. Volume7,793
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
47.97Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering344
GSEU Summary
The Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) is an investment fund that focuses on European companies across various industries and sizes, from large corporations to smaller businesses. It uses a strategy that balances factors like value, momentum, and quality to adapt to market changes. Some well-known companies in the fund include Nestlé and AstraZeneca. Investors might consider GSEU for diversification, as it provides exposure to many sectors and countries in Europe. However, since it is tied to European markets, its performance can be affected by economic or political changes in the region.
How much will it cost me?The Goldman Sachs ActiveBeta Europe Equity ETF (Ticker: GSEU) has an expense ratio of 0.25%, meaning you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed funds because it uses a systematic strategy to balance multiple factors, making it more efficient than many traditional active funds.
What would affect this ETF?The GSEU ETF, which focuses on European equities, could benefit from economic recovery in Europe, increased demand for healthcare and technology innovations, and stable financial sector performance, given its significant exposure to these areas. However, it may face challenges from rising interest rates, regulatory changes in Europe, or economic slowdowns that could negatively impact industrial and consumer sectors. Its diversified holdings across developed European markets provide some resilience against sector-specific risks.
GSEU Top 10 Holdings
The Goldman Sachs ActiveBeta Europe Equity ETF is leaning heavily on healthcare and financial giants to drive performance, with names like Novartis and Roche showing steady growth thanks to robust pipelines and strategic initiatives. Nestlé adds stability from the consumer defensive sector, while AstraZeneca’s rising momentum bolsters the fund’s healthcare exposure. However, HSBC has been lagging recently, holding back gains in the financial sector. With a clear focus on developed Europe and a balanced mix of sectors, this ETF offers a diversified approach, though its reliance on healthcare and financials is worth noting.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.84% | $3.18M | €358.11B | 50.10% | 78 Outperform | |
| SAP SE | 1.83% | $2.05M | €263.59B | 6.04% | 73 Outperform | |
| Novartis AG | 1.75% | $1.96M | CHF188.19B | 5.42% | 78 Outperform | |
| Roche Holding AG | 1.69% | $1.89M | CHF209.75B | 5.79% | 73 Outperform | |
| AstraZeneca | 1.64% | $1.84M | £194.50B | 13.62% | 75 Outperform | |
| HSBC Holdings | 1.57% | $1.76M | £184.03B | 50.32% | 79 Outperform | |
| Nestlé SA | 1.46% | $1.63M | CHF195.74B | 1.23% | 65 Neutral | |
| Shell (UK) | 1.32% | $1.48M | £166.03B | 11.81% | 77 Outperform | |
| Siemens | 1.28% | $1.43M | €193.45B | 37.04% | 74 Outperform | |
| Banco Santander | 1.24% | $1.39M | €130.00B | 111.73% | 66 Neutral |
GSEU Technical Analysis
Positive
―
Price Trends
43.49
Positive
42.87
Positive
40.62
Positive
Market Momentum
0.14
Positive
47.50
Neutral
28.31
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 43.90, equal to the 50-day MA of 43.49, and equal to the 200-day MA of 40.62, indicating a neutral trend. The MACD of 0.14 indicates Positive momentum. The RSI at 47.50 is Neutral, neither overbought nor oversold. The STOCH value of 28.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSEU.
GSEU Peer Comparison
Comparison Results
Performance Comparison
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
43.67
8.09
22.74%
VGK
Vanguard FTSE Europe ETF
―
―
―
EZU
iShares MSCI Eurozone ETF
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
―
―
―
FLEE
Franklin FTSE Europe ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents